Passage Bio, Inc.
PASG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$64,767 | -$102,062 | -$136,125 | -$185,386 |
| Dep. & Amort. | $3,081 | $3,721 | $3,679 | $1,543 |
| Deferred Tax | $0 | $0 | $0 | $2,778 |
| Stock-Based Comp. | $5,820 | $10,921 | $0 | $32,691 |
| Change in WC | $4,204 | $5,339 | -$8,491 | $11,420 |
| Other Non-Cash | $3,706 | $3,817 | $22,727 | $10,075 |
| Operating Cash Flow | -$47,956 | -$78,264 | -$118,210 | -$126,879 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$34 | -$146 | -$5,274 | -$25,642 |
| Net Acquisitions | $0 | $0 | $0 | $8,000 |
| Inv. Purchases | -$88,170 | -$129,432 | -$157,835 | -$202,546 |
| Inv. Sales/Matur. | $143,150 | $194,815 | $188,308 | $182,374 |
| Other Inv. Act. | $0 | $0 | $0 | -$8,000 |
| Investing Cash Flow | $54,946 | $65,237 | $25,199 | -$45,814 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $8,742 | $135 | $433 | $166,693 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $132 | $0 | -$1,786 | -$37 |
| Financing Cash Flow | $8,874 | $135 | -$1,353 | $166,656 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $15,864 | -$12,892 | -$94,364 | -$6,037 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,709 | $34,601 | $128,965 | $135,002 |
| End Cash | $37,573 | $21,709 | $34,601 | $128,965 |
| Free Cash Flow | -$47,990 | -$78,410 | -$123,484 | -$152,521 |